Scilex Holding (SCLX) Free Cash Flow (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Free Cash Flow of $900000.0 for Q1 2026, down 85.02% year-over-year from $6.0 million in Q1 2025, and up 105.15% on a QoQ basis from -$17.5 million in Q4 2025.

Scilex Holding (SCLX) Free Cash Flow (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Free Cash Flow for 7 consecutive years, with $900000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Free Cash Flow fell 85.02% year-over-year to $900000.0; the TTM figure through Mar 2026 stood at -$1.3 million (down 108.09% YoY), while the FY2025 annual figure was $3.7 million, down 80.97% from the prior year.
  • Free Cash Flow came in at $900000.0 for Q1 2026 at Scilex Holding, up from -$17.5 million in the prior quarter.
  • The five-year high for Free Cash Flow was $9.4 million in Q1 2024, with the low at -$17.5 million in Q4 2025.
  • Average Free Cash Flow over 5 years is -$1.1 million, with a median of $2.3 million recorded in 2024.
  • The largest YoY upside for Free Cash Flow was 1879.14% in 2022 against a maximum downside of 2136.1% in 2022.
  • Year by year, Free Cash Flow stood at -$725000.0 in 2022, then sank by 643.59% to -$5.4 million in 2023, then soared by 147.0% to $2.5 million in 2024, then sank by 789.46% to -$17.5 million in 2025, then surged by 105.15% to $900000.0 in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $900000.0, -$17.5 million, and $8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 3.01 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.47 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.56 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 547.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.93 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.48 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.43 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.18 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 346.00 Mn
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 900,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 900,000.00
Mar 31, 2026 900,000.00
Dec 31, 2025 -17.47 Mn
Dec 31, 2025 -17.47 Mn
Sep 30, 2025 8.19 Mn
Sep 30, 2025 8.19 Mn
Jun 30, 2025 7.09 Mn
Jun 30, 2025 7.09 Mn
Mar 31, 2025 6.01 Mn
Mar 31, 2025 6.01 Mn
Dec 31, 2024 2.53 Mn
Dec 31, 2024 2.53 Mn
Sep 30, 2024 5.11 Mn
Sep 30, 2024 5.11 Mn
Jun 30, 2024 2.31 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 9.39 Mn
Mar 31, 2024 9.39 Mn
Dec 31, 2023 -5.39 Mn
Dec 31, 2023 -5.39 Mn